Fatigue in Parkinson's disease patients

Current Treatment Options in Neurology

Volumn 11, Issue 3, 2009, Pages 186-190

  Friedman, Joseph H ^a  

^a Parkinson's Disease and Movement Disorders Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CITALOPRAM; DOPAMINE RECEPTOR STIMULATING AGENT; ESCITALOPRAM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEVODOPA; METHYLPHENIDATE; MODAFINIL; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SHORT ACTING DRUG;

ANEMIA; APATHY; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG TOLERABILITY; DYSTHYMIA; FATIGUE; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MENTAL PERFORMANCE; MORNING DOSAGE; MOTOR DYSFUNCTION; MUSCLE FATIGUE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOCIAL BEHAVIOR; WEIGHT REDUCTION;

EID: 64549110866     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-009-0022-8     Document Type: Review

References (30)

1. Ebadi M, Pfeiffer RF: Parkinson's Disease. Boca Raton, FL: CRC Press, 2005.
2. Herlofson K, Larsen JP: The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003, 107:1-6.
3. Zesiewicz TA, Patel Larson A, Hauser RA, Sullivan KL: Social Security Disability Insurance (SSDI) in Parkinson's disease. Disabil Rehabil 2007, 29:1934-1936.
4. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123.
5. Webster's Encyclopedic Unabridged Dictionary of the English Language. New York: Random House; 1996.
6. Brown RG, Dittner A, Findley L, Wessely SC: The Parkinson fatigue scale. Parkinsonism Relat Disord 2005, 11:49-55.
7. Friedman JH, Friedman H: Fatigue in Parkinson's disease. Neurology 1993, 43:2016-2018.
8. Funkiewicz A, Ardouin C, Caputo E, et al.: Long term effects of bilateral subthalamic stimulation on cognitive function, mood, and behavior in Parkinson's disease. J Neurol Neurosurg Psychiatry 2005, 75:834-839.
9. Ziv I, Avraham M, Michaelov Y, et al.: Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology 1998, 51:1583-1586.
10. Lou JS, Kearns G, Benice T, et al.: Levodopa improves physical fatigue in Parkinson's disease - a double-blind, placebo-controlled crossover study. Mov Disord 2003, 18:1108-1114.
11. Chaudhuri A, Behan PO: Fatigue and basal ganglia. J Neurol Sci 2000, 179:34-42.
12. Schifitto G, Friedman JH, Oakes D, et al.: Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 2008, 71:481-485.
13. Grace J, Amick MM, Friedman JH: A comparison of fatigue measures in Parkinson's disease. Parkinsonism Relat Disord 2007, 13:443-445.
14. Hoehn MMO Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
15. van Hilten JJ, Hoogland G, van der Velde EA, et al.: Diurnal effects of motor activity and fatigue in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993, 56:874-877.
16. van Hilten JJ, Weggeman M, van der Velde EA, et al.: Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993, 5:235-244.
17. Shulman L, Taback RL, Bean J, Weiner WJ: Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001, 16:507-510.
18. Schenkman M, Wei Zhu C, Cutson TM, Whetten-Goldstein K: Longitudinal evaluation of economic and physical impact of Parkinson's disease. Parkinsonism Relat Disord 2001, 8:41-50.
19. Karlsen K, Larsen JP, Tandberg E, Jorgensen K: Fatigue in patients with Parkinson's disease. Mov Disord 1999, 4:237-241.
20. Alves G, Wentzel-Larsen T, Larsen JP: Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology 2004, 63:1908-1911.
21. Abe K, Takanashi M, Yanagihara T: Fatigue in patients with Parkinson disease. Behav Neurol 2000, 12:103-106.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
23. Friedman JH, Friedman H: FAtigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001, 16:1120-1122.
24. Tzelepis GE, McCool FD, Friedman JH, Hoppin FG: Respiratory muscle dysfunction in Parkinson's disease. Am Rev Respir Dis 1988, 138:266-271.
25. Garber CE, Friedman JH: Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003, 60:1119-1124.
26. Abe K, Takanashi M, Yanagihara T, Sakoda S: Pergolide mesilate may improve fatigue in patients with Parkinson's disease. Behav Neurol 2001/ 2002, 13:117-121.
27. Pogarell O, Gasser T, van Hilten JJ, et al.: Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: A randomized, double blind, placebo controlled multicenter study. J Neurol Neurosurg Psychiatry 2002, 72:713-720.
28. Mendonca DA, Menezes K, Jog MS: Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial. Mov Disord 2007, 22:2070-2076.
29. Ondo WG, Fayle R, Atassi, Jankovic J: Modafinil for daytime somnolence in Parkinson's disease: Double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005, 76:1636-1639.
30. Adler CH, Caviness JN, Hentz GJ, et al.: Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003, 18:287-293.